76ers vs. Knicks: Latest injury update on OG Anunoby after leaving win

2 min read
76ers vs. Knicks: Latest injury update on OG Anunoby after leaving win

76ers vs. Knicks: Latest injury update on OG Anunoby after leaving win

Here is the latest injury update on New York Knicks forward OG Anunoby against the Philadelphia 76ers.

76ers vs. Knicks: Latest injury update on OG Anunoby after leaving win

Here is the latest injury update on New York Knicks forward OG Anunoby against the Philadelphia 76ers.

The Philadelphia 76ers and New York Knicks are locked in a heated playoff series, but both teams are now facing injury concerns. While the Sixers have been dealing with Joel Embiid's issues, the Knicks just received a major scare regarding key forward OG Anunoby.

In Wednesday's Game 2, Anunoby limped off the court late in the fourth quarter, grabbing his right leg. Despite scoring 24 points in the Knicks' 108-102 victory—which put them up 2-0 in the series—his status for the remainder of the playoffs is now uncertain. According to ESPN, Anunoby has been diagnosed with a right hamstring strain and is considered day-to-day, officially listed as questionable for Friday's Game 3 in Philadelphia.

This injury is eerily familiar for Knicks fans. In 2024, Anunoby suffered a left hamstring strain during Game 2 against the Indiana Pacers. The Knicks jumped out to a 2-0 lead, but Anunoby couldn't return until a hobbled Game 7 appearance, which ultimately ended in a series loss. Now, with the Knicks again up 2-0, history could be repeating itself.

Anunoby has been a playoff force for New York, averaging 21.4 points and 7.5 rebounds while shooting an impressive 53.8% from three-point range. If he's sidelined, the Sixers will have one less defensive nightmare to contend with—a potential turning point in the series. The action resumes Friday at 7 p.m. EDT at Xfinity Mobile Arena, and all eyes will be on Anunoby's availability.

Like this article?

Order custom jerseys for your team with free design

Related Topics

Related News

Back to All News